CSIMarket
 


Perkinelmer Inc  (PKI)
Other Ticker:  
 
 

PKI's Capital Expenditures Growth by Quarter and Year

Perkinelmer Inc's Capital Expenditures results by quarter and year




PKI Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter January - 49.40 7.77 11.02
III Quarter October - 5.62 8.43 11.83
II Quarter July - 4.48 6.02 18.06
I Quarter April 29.43 6.86 8.71 12.90
FY   29.43 66.36 30.93 53.81



PKI Capital Expenditures first quarter 2021 Y/Y Growth Comment
Perkinelmer Inc achieved in the first quarter 2021, above Company average Capital Expenditures surge of 329.02% year on year, to $ 29.43 millions.

Looking into first quarter 2021 results within Laboratory Analytical Instruments industry 8 other companies have achieved higher Capital Expenditures growth. While Perkinelmer Inc' s Capital Expenditures doubling of 329.02% ranks overall at the positon no. 2124 in the first quarter 2021.




PKI Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter January - 535.78 % -29.49 % 77.17 %
III Quarter October - -33.33 % -28.74 % 126.2 %
II Quarter July - -25.58 % -66.67 % -40.96 %
I Quarter April 329.02 % -21.24 % -32.48 % 43.17 %
FY   - 114.55 % -42.52 % 5.41 %

Financial Statements
Perkinelmer Inc's first quarter 2021 Capital Expenditures $ 29.43 millions PKI's Income Statement
Perkinelmer Inc's first quarter 2020 Capital Expenditures $ 6.86 millions Quarterly PKI's Income Statement
New: More PKI's historic Capital Expenditures Growth >>


PKI Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter January - 779 % -7.83 % -6.85 %
III Quarter October - 25.45 % 40.03 % -34.5 %
II Quarter July - -34.69 % -30.88 % 40 %
I Quarter April -40.42 % -11.71 % -20.96 % 107.4 %
FY (Year on Year)   - 114.55 % -42.52 % 5.41 %




Capital Expenditures first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #9
Healthcare Sector #302
Overall #2124

Capital Expenditures Y/Y Growth Statistics
High Average Low
278.73 % 27.34 % -100 %
(Apr 01 2018)   (Jan 01 2012)
Capital Expenditures first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #9
Healthcare Sector #302
Overall #2124
Capital Expenditures Y/Y Growth Statistics
High Average Low
278.73 % 27.34 % -100 %
(Apr 01 2018)   (Jan 01 2012)

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Perkinelmer Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
181.04 % 6.6 % -100 %
(Sep. 30, 2009)  


PKI's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2021 Perkinelmer Inc reported fall in Capital Expenditures from the previous quarter by -40.42% to $ 29.43 millions, from $ 49.40 millions achived in the previous quarter.

But that's not important issue, as Perkinelmer Inc's Capital Expenditures frequently seem to slow in this quarter.

Within Laboratory Analytical Instruments industry 10 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Perkinelmer Inc's Capital Expenditures growth quarter on quarter, overall rank is 2655.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #11
Healthcare Sector #320
Overall #2655
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #11
Healthcare Sector #320
Overall #2655
Capital Expenditures Q/Q Growth Statistics
High Average Low
181.04 % 6.6 % -100 %
(Sep. 30, 2009)  


PKI's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2021 Perkinelmer Inc reported fall in Capital Expenditures from the fourth quarter by -40.42% to $ 29.43 millions, from $ 49.40 millions achived a quarter before.

But that's not big issue, as Perkinelmer Inc's Capital Expenditures frequently gravitate to dip in the I. Quarter.

Within Laboratory Analytical Instruments industry 10 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Perkinelmer Inc's Capital Expenditures growth quarter on quarter, overall rank is 2655.


Perkinelmer Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Jan 02 2022)
12 Months Ending
(Sep. 30, 2015)
12 Months Ending
IV. Quarter
12 Months Ending
IV. Quarter
Cumulative Capital Expenditures 12 Months Ending $ 88.93 $ 66.36 $ 24.67 $ 24.72 $ 27.53
Y / Y Capital Expenditures Growth (TTM) 205.91 % 114.58 % -16.76 % -27.67 % -26.75 %
Year on Year Capital Expenditures Growth Overall Ranking # 1190 # 830 # 2795 # 1666 # 2036
Seqeuential Capital Expenditures Change (TTM) 34.02 % 168.4 % -0.21 % -10.2 % -5.3 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1845 # 36 # 3129 # 1047 # 2031




Cumulative Capital Expenditures growth Comment
Perkinelmer Inc saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 205.91% year on year, to $ 89 millions if the fiscal year would have ended in Apr 03 2022.
Perkinelmer Inc's trailing twelve months Capital Expenditures growth was higher than company's average 24.21% and higher than 114.58% growth in Jan 02 2022.
But from twelve months ended Jan 02 2022 growth rate was beneth at 34.02 % from $66.36 millions reported in twelve months ending a quarter Jan 02 2022.
In spite of, it was evidence of strength, as the typical sequential Capital Expenditures gain is at 8.95%.
The growth was even stronger from twelve months ended Jan 02 2022 clinched at 34.02 % rise from $66.36 millions in twelve months ending a quarter before.

In the Healthcare sector 166 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 830 to 1190.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
233.37 %
8.95 %
-69.81 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 9
Healthcare Sector # 167
Overall # 1190

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
282.5 %
24.21 %
-74.42 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 249
S&P 500 # 1845
Cumulative Capital Expenditures growth Comment
Perkinelmer Inc saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 205.91% year on year, to $ 89 millions if the fiscal year would have ended in Apr 03 2022.
Perkinelmer Inc's trailing twelve months Capital Expenditures growth was higher than company's average 24.21% and higher than 114.58% growth in Jan 02 2022.
But sequential rise was less at 34.02 % from $66.36 millions recorded in twelve months ending a quarter Jan 02 2022.
Still this was confirmation of strength, while the average sequential gain lays at 8.95%.
The growth is even higher from twelve months ended Jan 02 2022 showed at 34.02 % jump from $66.36 millions in twelve months ending a quarter before.

In the Healthcare sector 166 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 830 to 1190.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
233.37 %
8.95 %
-69.81 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 9
Healthcare Sector # 167
Overall # 1190

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
282.5 %
24.21 %
-74.42 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 249
S&P 500 # 1845




Other Capital Expenditures Growth
Laboratory Analytical Instruments Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
PKI's Capital Expenditures Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for PKI's Competitors
Capital Expenditures Growth for Perkinelmer Inc's Suppliers
Capital Expenditures Growth for PKI's Customers

You may also want to know
PKI's Annual Growth Rates PKI's Profitability Ratios PKI's Asset Turnover Ratio PKI's Dividend Growth
PKI's Roe PKI's Valuation Ratios PKI's Financial Strength Ratios PKI's Dividend Payout Ratio
PKI's Roa PKI's Inventory Turnover Ratio PKI's Growth Rates PKI's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Apr 03 2022
Avid Bioservices Inc 492.38%$ 492.380 millions
Haemonetics Corporation201.88%$ 201.883 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com